Net Deals Web Search

Search results

1. Results From The WOW.Com Content Network

2. Moxifloxacin - Wikipedia

   en.wikipedia.org/wiki/Moxifloxacin

   Moxifloxacin is an antibiotic, used to treat bacterial infections, [4] including pneumonia, conjunctivitis, endocarditis, tuberculosis, and sinusitis. [4] [5] It can be given by mouth, by injection into a vein, and as an eye drop. [5] Common side effects include diarrhea, dizziness, and headache. [4]

3. Novo Nordisk, Lilly must cut US prices of weight-loss drugs ...

   www.aol.com/news/novo-nordisk-must-cut-prices...

   A month's supply of Novo's diabetes drug Ozempic carries a list price of $935.77 in the U.S., while its obesity treatment Wegovy is priced at $1,349.02 per month, according to the drugmaker's website.

4. Alcon - Wikipedia

   en.wikipedia.org/wiki/Alcon

   Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]

5. List of soft contact lens materials - Wikipedia

   en.wikipedia.org/wiki/List_of_soft_contact_lens...

   Types. The FDA classifies soft contact lenses into four groups for the US market. They are also subcategorized into 1st generation, 2nd generation, and 3rd generation lens materials. [6] These 'water-loving' soft contact lens materials are categorized as "Conventional Hydrophilic Material Groups ("-filcon"): Group. Water Content.

6. Alcon (ALC) Launches Preservative-Free Drops for Dry Eye Relief

   www.aol.com/news/alcon-alc-launches-preservative...

   For premium support please call: 800-290-4726 more ways to reach us

7. Novo Nordisk CEO to testify in US Senate hearing on ... - AOL

   www.aol.com/news/novo-nordisk-ceo-testify-us...

   June 14, 2024 at 5:40 PM. (Reuters) -The Senate Committee on Health, Education, Labor, and Pensions said on Friday that Novo Nordisk CEO Lars Jorgensen has agreed to testify voluntarily in a ...